Categories
Business Coronavirus Headlines Marketing News

Gastrointestinal Diseases Drug Development Market 2020-2026 COVID-19 Pandemic Shaping Global Demand | Leading Players – RedHill, GlaxoSmithKline plc, Avexegen Therapeutics, Inc., Knight Therapeutics Inc., Daewon Pharmaceutical Co. Ltd

Gastrointestinal Diseases Drug Development Market

A proficient data and brilliant forecasting techniques used in this Gastrointestinal Diseases Drug Development Market report are synonymous with accurateness and correctness. The document is a meticulous analysis of existing scenario of the market, which covers several market dynamics. This market research report endows with the plentiful insights and business solutions that will support to stay ahead of the competition. The most precise way to forecast what future holds is to understand the trend today and hence Gastrointestinal Diseases Drug Development Marketing report has been structured by chewing over numerous fragments of the present and upcoming market scenario.

Get Sample Analysis of Global Market : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-gastrointestinal-diseases-drug-development-market

This Gastrointestinal Diseases Drug Development Market report is the consequence of incessant efforts lead by clued-up forecasters, innovative analysts and bright researchers who indulge in detailed and attentive research on different markets, trends and emerging opportunities in the consecutive direction for the business needs. Company snapshot, geographical presence, product portfolio, and recent developments are taken into account for studying the company profiles that are part of this report. Quality and transparency has been strictly maintained while carrying out research studies to offer an exceptional market research report for a niche. A thoughtful knowledge of industrial unanimity, market trends and incredible techniques via this Gastrointestinal Diseases Drug Development Market report gives an upper hand in the market.

Global gastrointestinal diseases drug development market is rising gradually with a healthy CAGR in the forecast period of 2019-2026. Growing prevalence of gastrointestinal disorders worldwide and pharmaceuticals companies operating in gastrointestinal diseases pipeline space are the key factors for market growth.

Few of the major competitors currently working in the global gastrointestinal diseases drug development market are Kyowa Kirin Co., Ltd, Ardelyx, Shanghai Fosun Pharmaceutical (Group)Co., Ltd., RedHill, GlaxoSmithKline plc, Avexegen Therapeutics, Inc., Knight Therapeutics Inc., Daewon Pharmaceutical Co., Ltd, Metacrine, Vaxart, Inc, Takeda Pharmaceutical Company Limited, SynAct Pharma AB, Sequella, Inc, Prometic Life Sciences Inc, SHIELD THERAPEUTICS, Mitsubishi Tanabe Pharma Corporation, Salix Pharmaceuticals, Abbott, F. Hoffmann-La Roche Ltd, Pfizer Inc, ABIVAX among others

Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-gastrointestinal-diseases-drug-development-market

Market Definition: Global Gastrointestinal Diseases Drug Development Market

Gastrointestinal diseases are defined as the condition or disease that occurs within the gastrointestinal tract. The gastrointestinal disorders includes constipation, irritable bowel syndrome, colitis, inflammatory bowel disease and hence forth. The patients with gastrointestinal disorders may experience abdominal pain and cramps, bloating and change in bowel habits.

According to the articles published in the Oxford University Press by Journal of the Canadian Association of Gastroenterology, it was estimated up to 270,000 patients are living with inflammatory bowel disease and 135,000 patients with Crohn’s disease in the Canada in the year of 2018. These growing cases of gastrointestinal diseases and high demand of disease specific treatment are factors to drive the market growth.

Segmentation: Global Gastrointestinal Diseases Drug Development Market

Gastrointestinal Diseases Drug Development Market : By Disease Type

  • Gastroenteritis
  • Inflammatory bowel disease (IBD)
  • Irritable bowel syndrome
  • Others

Gastrointestinal Diseases Drug Development Market : By Molecular targets

  • Sodium Transporter Nhe3 Inhibitor
  • Sphinogosine-1-Phosphate Receptor Functional Antagonist
  • Tumor Necrosis Factor (TNF) Blocker
  • Others

Gastrointestinal Diseases Drug Development Market : By Marketed Drugs

  • Infliximab
  • Adalimumab
  • Mesalazine
  • Others

Gastrointestinal Diseases Drug Development Market : By Clinical Trials

  • Etrolizumab
  • SHP647
  • ABX464
  • ASP3291
  • Others

Gastrointestinal Diseases Drug Development Market : By Route of Administration

  • Oral
  • Injectable

Gastrointestinal Diseases Drug Development Market : By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Gastrointestinal Diseases Drug Development Market : By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Key Developments in the Gastrointestinal Diseases Drug Development Market:

  • In June 2019, Knight Therapeutics Inc, filed New Drug Submission (NDS) to the Health Canada for Ibsrela, (tenapanor), an oral sodium transporter NHE3 inhibitor for the treatment of irritable bowel syndrome in patients with constipation. Upon approval of Ibsrela, it will change the treatment landscape to the physician as well as patients suffering from irritable bowel syndrome throughout the Canada
  • In November 2018, Ardelyx received FDA’s acceptance of New Drug Application (NDA) for Tenapanor, sodium transporter NHE3 inhibitor for the treatment of irritable bowel syndrome in patients with constipation. If approved it will shift from standard symptomatic treatment to the disease specific treatment

Gastrointestinal Diseases Drug Development Market Drivers

  • Introduction of biologics for the treatment of gastrointestinal diseases is boosting the gastrointestinal diseases drug development market
  • High prevalence of gastrointestinal disorders worldwide will drive the market growth
  • On-going clinical trial is being conducted by the many pharmaceuticals companies also acts as a market driver
  • New launches of products annually is propelling the market growth

Gastrointestinal Diseases Drug Development Market Restraints

  • Huge expenditure involved in research and development will restrict the market growth
  • Patent expiry of major drugs and introduction of generic drugs of branded version is expected to hamper the market growth
  • Limited success rate of novel therapies will hamper the market growth

Opportunities in the Gastrointestinal Diseases Drug Development Market Report :

  1. Comprehensive quantitative analysis of the industry is provided for the period of 2020-2026 to assist stakeholders to capitalize on the prevailing market opportunities.
  2. Comprehensive analysis of the factors that drive and restrict the market growth is provided in the Gastrointestinal Diseases Drug Development Market report.
  3. Extensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across regional.
  4. Extensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across Global.

Want Full Report? Enquire Here @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-gastrointestinal-diseases-drug-development-market

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475
Mail: [email protected]